THURSDAY, Oct. 7 (HealthDay News) — Two new studies confirm that the immunity offered by two doses of Pfizer’s coronavirus vaccine drops off after about two months, although protection against severe disease, hospitalization and death holds strong. The reports, from Israel and Qatar, add to evidence that suggests even fullyContinue Reading
WEDNESDAY, Oct. 6, 2021 (HealthDay News) — The first vaccine to protect against malaria has been endorsed by the World Health Organization (WHO) and could prevent the deaths of tens of thousands of children a year. Malaria kills about half a million people worldwide annually. Nearly all of those deathsContinue Reading
WEDNESDAY, Oct. 6, 2021 (HealthDay News) — Since the rise of the Delta variant, one Texas hospital has seen a surge in severe COVID-19 among pregnant women — nearly all unvaccinated. Researchers at the Dallas hospital found that in late August and early September, 10% to 15% of pregnant patientsContinue Reading
WEDNESDAY, Oct. 6, 2021 (HealthDay News) — The rate at which homicide is taking the lives of Americans jumped by 30% over the first year of the COVID-19 pandemic — the largest year-to-year increase ever, new federal government figures show. The rate jumped from 6 homicides per 100,000 people inContinue Reading
WEDNESDAY, Oct. 6, 2021 (HealthDay News) — Drug and alcohol abuse increase the risk of breakthrough COVID-19 infection as well as severe illness and death among fully vaccinated people, a new study shows. “First and foremost, vaccination is highly effective for people with substance use disorders, and the overall riskContinue Reading
TUESDAY, Oct. 5, 2021 (HealthDay News) — Statins are proven to lower cholesterol, but they may also come with a downside for patients with diabetes: A new study finds they may make the blood sugar disease worse. Researchers found that among those taking statins, 56% saw their diabetes progress, comparedContinue Reading
TUESDAY, Oct. 5, 2021 (HealthDay News) — Nearly half of Americans have high blood pressure and only 24% have it under control, but what’s the best way to treat it — one high-dose pill or two at a lower dose? A large new study suggests that two medications may beContinue Reading
TUESDAY, Oct. 5, 2021 (HealthDay News) — Johnson & Johnson announced Tuesday that it has asked the U.S. Food and Drug Administration to approve emergency use of its coronavirus booster shot. The request to authorize an extra vaccine dose for people who’ve previously received Johnson & Johnson’s single-shot vaccine wasContinue Reading
TUESDAY, Oct. 5, 2021 (HealthDay News) — Full vaccination with the two-dose Pfizer COVID-19 vaccine has been 90% effective in protecting against hospitalization for at least six months, a new study shows. That includes the time during which the highly contagious Delta variant has been circulating in the United States.Continue Reading
TUESDAY, Oct. 5, 2021 (HealthDay News) — Misinformation and medical mistrust are major drivers of vaccine hesitancy among U.S. Hispanics, new research shows. The researchers also found that protecting other family members is an important factor in convincing Hispanics to get vaccinated. The small study included 22 Hispanic mothers inContinue Reading
TUESDAY, Oct. 5, 2021 (HealthDay News) — The ongoing coronavirus pandemic has hit minority groups in the United States hard, with significantly more deaths among Black and Hispanic Americans compared with white and Asian Americans, a new study finds. According to the report, these disparities highlight the need to addressContinue Reading
MONDAY, Oct. 4, 2021 (HealthDay News) — Booster shots of the Pfizer-BioNTech coronavirus vaccine for people aged 18 and older have been given the green light by the European Medicines Agency. They “may be considered at least six months after the second dose for people aged 18 years and older,”Continue Reading
MONDAY, Oct. 4, 2021 (HealthDay News) — People newly infected with COVID-19 might soon have access to what essentially is Tamiflu for the novel coronavirus, a breakthrough that experts say would drastically alter the course of the ongoing pandemic. At least three contenders are vying to become the first antiviralContinue Reading
MONDAY, Oct. 4, 2021 (Healthday News) — Johnson & Johnson plans to ask the U.S. Food and Drug Administration to approve emergency use of a booster shot of its single-dose COVID-19 vaccine early this week. While the request has yet to be submitted, the FDA on Friday scheduled an Oct.Continue Reading